Eyal Shoshani

Eyal Shoshani is a seasoned clinical affairs professional with extensive experience in clinical operations and management within the biotechnology and pharmaceutical industries. Currently serving as Vice President of Clinical Affairs at PolyPid Ltd. since September 2024, Eyal previously held the position of Vice President of Clinical Operations at Gamida Cell Ltd. from October 2021 to September 2024. Before that, Eyal acted as Head of Clinical Operations at Minovia Therapeutics, where responsibilities included establishing a clinical operations department, managing clinical studies, and overseeing budget and resource allocation. Eyal's career also encompasses leadership roles at Pluristem Therapeutics, Dexcel Pharma, and Quintiles, with expertise in clinical trial management, regulatory compliance, and operational performance. Eyal holds a B.Sc in Biotechnology Engineering from Ben-Gurion University of the Negev and an MBA in Business Administration from The Open University of Israel.